Search - tctmd.com

Displaying 141 - 160 of 190

Sort: Relevancy | Date

News Conference News ACC 2016

Valve Hemodynamic Deterioration Post-TAVR Is Rare, Not Linked With Adverse Cardiovascular Outcomes

Michael O'Riordan

April 07, 2016

News Industry News

St. Jude Medical Announces the European Launch of the Trifecta Surgical Valve with Glide Technology to Improve Options for Patients in Need of Aortic Valve Replacement

April 07, 2016

News Industry News

LivaNova PLC Announces the First Patient Enrolled in the PERSIST-AVR Trial

April 04, 2016

News Opinion Editor's Corner

ACC 2016: HOPE for Primary Prevention, TAVR in Moderate-Risk Patients, Deferred Stenting in STEMI, and More

Shelley Wood

March 28, 2016

News Daily News

Cardiac Surgery Risk Prediction with EuroSCORE Improved with Updated, Dynamic Modeling

Michael O'Riordan

March 01, 2016

News Daily News

在 TAVR 患者中观察到瓣膜血流动力学的亚临床变化

Michael O'Riordan

February 08, 2016

News Daily News

Subclinical Changes in Valve Hemodynamics Observed in TAVR Patients

Michael O'Riordan

February 08, 2016

News Daily News

Se Observan Cambios Subclínicos en la Hemodinámica Valvular en Pacientes TAVR

Michael O'Riordan

February 08, 2016

Presentation

Incidence, Timing, and Predictors of Valve Hemodynamic Deterioration After TAVR

Presenter: M. Del Trigo

February 07, 2016

News Conference News TCT 2015

Low 1-Year Event Rates Seen After TAVR With Sapien 3

Todd Neale

October 15, 2015

News Industry News

Edwards SAPIEN 3 Valve Demonstrates High Survival And Low Stroke Rate At 1 Year

October 15, 2015

News Conference News TCT 2015

MISTRAL-C: Cerebral Protection in TAVR May Reduce New Lesions

October 14, 2015

News Industry News

Sorin Group Starts First Randomized, Controlled Trial Comparing the Perceval Sutureless Valve to Standard Bioprostheses

October 06, 2015

News Industry News

Valtech's Cardioband® Receives CE Mark Approval for Mitral Valve Repair

September 14, 2015

News Industry News

First North American Trial Results Reinforce the Safety and Hemodynamic Performance of Sorin’s Solo Smart Pericardial Aortic Valve

June 24, 2015

News Industry News

First One-Year Report Of Outcomes With Edwards SAPIEN 3 Valve Demonstrate High Survival And Low Stroke Rate

May 19, 2015

News Daily News

PARTNER at 5 Years: TAVR Shows Durable Benefit in Inoperable Patients

March 25, 2015

News Conference News ACC 2015

Follow-up TAVR Studies Reassure About Valve Durability, Outcomes

Todd Neale

March 15, 2015

News Industry News

Five-Year Outcomes For High-Risk Sapien Patients Demonstrate Equivalence To Surgery, Durable Valve Performance

March 15, 2015

Presentation TCT 2014

Treatment of Bio-Prosthetic Valve Deterioration Using The Valve-in-Valve Technique

Presenter: Ran Kornowski

September 16, 2014

Advertisement

Valve Hemodynamic Deterioration Post-TAVR Is Rare, Not Linked With Adverse Cardiovascular Outcomes

St. Jude Medical Announces the European Launch of the Trifecta Surgical Valve with Glide Technology to Improve Options for Patients in Need of Aortic Valve Replacement

LivaNova PLC Announces the First Patient Enrolled in the PERSIST-AVR Trial

ACC 2016: HOPE for Primary Prevention, TAVR in Moderate-Risk Patients, Deferred Stenting in STEMI, and More

Cardiac Surgery Risk Prediction with EuroSCORE Improved with Updated, Dynamic Modeling

在 TAVR 患者中观察到瓣膜血流动力学的亚临床变化

Subclinical Changes in Valve Hemodynamics Observed in TAVR Patients

Se Observan Cambios Subclínicos en la Hemodinámica Valvular en Pacientes TAVR

Incidence, Timing, and Predictors of Valve Hemodynamic Deterioration After TAVR

Low 1-Year Event Rates Seen After TAVR With Sapien 3

Edwards SAPIEN 3 Valve Demonstrates High Survival And Low Stroke Rate At 1 Year

MISTRAL-C: Cerebral Protection in TAVR May Reduce New Lesions

Sorin Group Starts First Randomized, Controlled Trial Comparing the Perceval Sutureless Valve to Standard Bioprostheses

Valtech's Cardioband® Receives CE Mark Approval for Mitral Valve Repair

First North American Trial Results Reinforce the Safety and Hemodynamic Performance of Sorin’s Solo Smart Pericardial Aortic Valve

First One-Year Report Of Outcomes With Edwards SAPIEN 3 Valve Demonstrate High Survival And Low Stroke Rate

PARTNER at 5 Years: TAVR Shows Durable Benefit in Inoperable Patients

Follow-up TAVR Studies Reassure About Valve Durability, Outcomes

Five-Year Outcomes For High-Risk Sapien Patients Demonstrate Equivalence To Surgery, Durable Valve Performance

Treatment of Bio-Prosthetic Valve Deterioration Using The Valve-in-Valve Technique

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content